| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 5 | 29 | 1 | 0 | 1 | 3 | 39 | ||
| OG | 11 | 25 | 1 | 0 | 1 | 1 | 39 | ||
| OD + OG | 16 | 54 | 2 | 0 | 2 | 4 | 78 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 12,82% | 74,36% | 2,56% | 0,00% | 2,56% | 7,69% | 100,00% | ||
| OG | 28,21% | 64,10% | 2,56% | 0,00% | 2,56% | 2,56% | 100,00% | ||
| MOYENNE | 20,51% | 69,23% | 2,56% | 0,00% | 2,56% | 5,13% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 2 | 15 | 1 | 0 | 1 | 1 | 20 | ||
| 10,00% | 75,00% | 5,00% | 0,00% | 5,00% | 5,00% | 100,00% | |||
| FEMMES | 1 | 14 | 1 | 0 | 1 | 2 | 19 | ||
| 5,26% | 73,68% | 5,26% | 0,00% | 5,26% | 10,53% | 100,00% | |||
| TOTAL | 3 | 29 | 2 | 0 | 2 | 3 | 39 | ||
| 7,69% | 74,36% | 5,13% | 0,00% | 5,13% | 7,69% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||